News & Insights

Praedicat in the news.

Read what we think and what others think, all meant to make you think.

Praedicat Posts on Litigation

Milliman report, The “forever chemical” risk is now: An actuarial reserving study can help insurers prepare for PFAS claims and litigation
Milliman report, The “forever chemical” risk is now: An actuarial reserving study can help insurers prepare for PFAS claims and litigation 1031 537 Yvonne Torres

Our own David Loughran and Graham Tibbets join Matthew B. Anderson, Travis Grulkowski and Drew Goth to co-author the newest report from Milliman, The “forever chemical” risk is now: An…

read more

Praedicat Blog – Is aspartame the next glyphosate?
Praedicat Blog – Is aspartame the next glyphosate? 880 458 Sheryll Mangahas

Praedicat Blog – Is aspartame the next glyphosate? by Adam Grossman and Sheryll Mangahas In March 2015, the World Health Organisation’s (WHO) International Agency for Research on Cancer (IARC) declared…

read more

Carrier Management – Endocrine Disruption Litigation Has Arrived
Carrier Management – Endocrine Disruption Litigation Has Arrived 1536 864 Yvonne Torres

June 8, 2023: Endocrine Disruption Litigation Has Arrived In their latest article for Carrier Management, Praedicat’s David Loughran and Adam Grossman explore the emergence of endocrine disruption as a major…

read more

Praedicat Video: Lloyd’s Lab Demo Day 2020
Praedicat Video: Lloyd’s Lab Demo Day 2020 150 150 Meghan Dengler

Praedicat Lloyd’s Lab Demo Day 2020 We are excited and proud of our work in the Lab! A tremendous THANK YOU  to our mentors and everyone in the Lloyd’s market…

read more

Praedicat Press Release: Lloyd’s Lab Demo Day 2020
Praedicat Press Release: Lloyd’s Lab Demo Day 2020 700 350 Meghan Dengler

November 18th 2020: Praedicat press release on our participation in Lloyd’s Lab Cohort 5 Demo Day We are excited and proud of our work in the Lab! A tremendous THANK…

read more

Praedicat Participates in Rand Corp Opioid Symposium
Praedicat Participates in Rand Corp Opioid Symposium 750 350 Bob Reville

Praedicat CEO Presents at Rand’s Opioid Symposium: There is still time to register for the Rand Corporation’s latest symposium: Opioid Litigation: What’s New and What Does It Mean for Future…

read more

RIMS Risk Management Monitor – Take Home COVID-19 Claims – Second Wave Litigation
RIMS Risk Management Monitor – Take Home COVID-19 Claims – Second Wave Litigation 150 150 Meghan Dengler

October 4th, 2020: In the RIMS Risk Management Monitor article, ‘‘Take-Home COVID-19’ Claims: Preparing for a Second Wave of Coronavirus Litigation’, Praedicat Head of Product and Chief Economist, Dr. David Loughran deliberates…

read more

Praedicat Press Release: Litigation Tracker
Praedicat Press Release: Litigation Tracker 757 350 Meghan Dengler

July 27th 2020: Praedicat press release on our COVID-19 Litigation Tracker Praedicat has released updates to our unprecedented Litigation Tracker, which monitors emerging SARS-CoV-2 litigation complaint by complaint. With more…

read more

Praedicat Launches COVID-19 Litigation Tracker
Praedicat Launches COVID-19 Litigation Tracker 1280 450 Meghan Dengler

June 25th, 2020: Praedicat announces the launch of our unprecedented COVID-19 Litigation Tracker Praedicat is proud to introduce our new Litigation Tracker, which monitors emerging SARS-CoV-2 litigation complaint by complaint.…

read more

Oxbow Partners Bitesize Interview
Oxbow Partners Bitesize Interview 750 350 Meghan Dengler

May 9th 2020: In the Bitesize article, Oxbow Partners gives a first glimpse of Praedicat’s COVID-19 scenario modelling solution and litigation tracker, both of which are set to launch later…

read more

Insurance ERM: Praedicat Scenario Tool Targets COVID-19 Litigation Assessments
Insurance ERM: Praedicat Scenario Tool Targets COVID-19 Litigation Assessments 750 350 Meghan Dengler

April 29th: In an article published by Insurance ERM, Praedicat scenario tool targets Covid-19 litigation assessments, Robert Reville, Praedicat CEO, discusses the upcoming launch of a suite of tools to…

read more

A.M. Best Review – Legal Maneuvers
A.M. Best Review – Legal Maneuvers 700 350 Meghan Dengler

April 1st, 2020 – Kate Smith, from A.M. Best Review interviewed Bob Reville, CEO of Praedicat, on the shifting litigation landscape and the recent 4th party litigation on opioids. In…

read more
Start Typing